Actual Medicinal Product (AMP) - Tadomon 250mg prolonged-release tablets (G.L. Pharma UK Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Current Name | Tadomon 250mg prolonged-release tablets | 05-03-2024 | |
Summary
- Controlled Drug Category
- Schedule 2 (CD)
- Licensed Route
- Oral
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
Codes
| Code | Start Date | End Date |
|---|---|---|
| 42675511000001100 | 05-03-2024 |
Parent Products
-
VTMTapentadol
-
VMPTapentadol 250mg modified-release tablets
-
AMP(Current) Tadomon 250mg prolonged-releas... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 56 tablet | 6228 |